Profil
Daniel J.
Kenan is the founder of Affinergy LLC, a company founded in 2002, where he holds the title of Scientific Officer.
He is currently working as the Director at the Combinatorial Sciences Center since 1997 and as an Assistant Professor at Duke University since 2012.
Dr. Kenan obtained his doctorate degree from Duke University.
Postes actifs de Daniel J. Kenan
| Sociétés | Poste | Début |
|---|---|---|
Affinergy LLC
 Affinergy LLC BiotechnologyHealth Technology Affinergy LLC develops site-specific biological systems using biofriendly linkers that selectively adhere to proteins, drugs, cells, and biomaterial surfaces. The firm focuses on developing coatings and medical devices for the orthopedic and cardiovascular markets. It constructs bifunctional peptide linkers that selectively immobilize proteins, cells, and therapeutics onto biomaterial surfaces. The firm offers its products for orthopedics, cardiovascular, and tissue engineering; and drug delivery and stem cells markets. The company was founded by Daniel J. Kenan, Jonathan Gindes, and Mark W. Grinstaff in 2002 and is headquartered in Durham, NC. | Fondateur | 01/01/2002 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
| Combinatorial Sciences Center | Directeur/Membre du Conseil | 01/01/1997 |
Formation de Daniel J. Kenan
| Duke University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Affinergy LLC
Affinergy LLC BiotechnologyHealth Technology Affinergy LLC develops site-specific biological systems using biofriendly linkers that selectively adhere to proteins, drugs, cells, and biomaterial surfaces. The firm focuses on developing coatings and medical devices for the orthopedic and cardiovascular markets. It constructs bifunctional peptide linkers that selectively immobilize proteins, cells, and therapeutics onto biomaterial surfaces. The firm offers its products for orthopedics, cardiovascular, and tissue engineering; and drug delivery and stem cells markets. The company was founded by Daniel J. Kenan, Jonathan Gindes, and Mark W. Grinstaff in 2002 and is headquartered in Durham, NC. | Health Technology |
| Combinatorial Sciences Center |